The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
Clinical trial NCT03546530 · COMPLETED
Trial details
- NCT number
- NCT03546530
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-01-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.